| Dr Richard Lewis Bendinger Jr, DO | |
|
615 Ozark Rd, Abbeville, AL 36310-2629 | |
| (334) 585-1171 | |
| (334) 585-1182 |
| Full Name | Dr Richard Lewis Bendinger Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 615 Ozark Rd, Abbeville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558321786 | NPI | - | NPPES |
| 125526 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | DO89 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gentiva Hospice - Dothan | Dothan, AL | Hospice |
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Flowers Hospital | Dothan, AL | Hospital |
| Medical Center Barbour | Eufaula, AL | Hospital |
| Henry County Health And Rehabilitation Facility | Abbeville, AL | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Alabama Rural Health Associates | 8123009057 | 24 |
News Archive
The Contra Costa Times: "Six months after passage of the federal health reform law, major provisions will kick in that supporters say will make it easier for Americans to get and keep health insurance. … Among the major changes: Insurance companies will no longer be able to cancel policies because someone becomes sick, set lifetime caps on coverage or deny insurance to children with pre-existing conditions. … In addition to enabling young people to remain on their parents' policies up to age 26, several other major provisions kick in on Thursday.
Harvest Technologies Corp. announced today that the FDA has approved the company sponsored 210-patient IDE clinical trial to be conducted at twenty-five sites in the U.S. using the company's proprietary Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI).
Women with coronary artery disease who completed a 12-week cardiac rehabilitation program were two-thirds less likely to die compared to those who were not referred to the program.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
› Verified 8 days ago
| Entity Name | Southeast Alabama Rural Health Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891856134 PECOS PAC ID: 8123009057 Enrollment ID: O20040526001591 |
News Archive
The Contra Costa Times: "Six months after passage of the federal health reform law, major provisions will kick in that supporters say will make it easier for Americans to get and keep health insurance. … Among the major changes: Insurance companies will no longer be able to cancel policies because someone becomes sick, set lifetime caps on coverage or deny insurance to children with pre-existing conditions. … In addition to enabling young people to remain on their parents' policies up to age 26, several other major provisions kick in on Thursday.
Harvest Technologies Corp. announced today that the FDA has approved the company sponsored 210-patient IDE clinical trial to be conducted at twenty-five sites in the U.S. using the company's proprietary Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI).
Women with coronary artery disease who completed a 12-week cardiac rehabilitation program were two-thirds less likely to die compared to those who were not referred to the program.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Lewis Bendinger Jr, DO 1414 Elba Hwy, Troy, AL 36079-6020 Ph: (334) 670-6726 | Dr Richard Lewis Bendinger Jr, DO 615 Ozark Rd, Abbeville, AL 36310-2629 Ph: (334) 585-1171 |
News Archive
The Contra Costa Times: "Six months after passage of the federal health reform law, major provisions will kick in that supporters say will make it easier for Americans to get and keep health insurance. … Among the major changes: Insurance companies will no longer be able to cancel policies because someone becomes sick, set lifetime caps on coverage or deny insurance to children with pre-existing conditions. … In addition to enabling young people to remain on their parents' policies up to age 26, several other major provisions kick in on Thursday.
Harvest Technologies Corp. announced today that the FDA has approved the company sponsored 210-patient IDE clinical trial to be conducted at twenty-five sites in the U.S. using the company's proprietary Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI).
Women with coronary artery disease who completed a 12-week cardiac rehabilitation program were two-thirds less likely to die compared to those who were not referred to the program.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
› Verified 8 days ago
Dr. Richard V. Meadows, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 217 Dothan Rd, Abbeville, AL 36310 Phone: 334-585-6421 Fax: 334-585-6159 |